Cargando…

Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051791/ http://dx.doi.org/10.1007/s40278-022-14048-x

Ejemplares similares

Rituximab: Hypogammaglobulinaemia: 2 case reports
Publicado: (2021)

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publicado: (2021)

Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022)

Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Publicado: (2022)

Bendamustine/remdesivir/rituximab: Emergence of drug resistance and SARS-CoV-2 viraemia due to B-cell immunodeficiency : case report
Publicado: (2021)

Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
por: Daniel, Jefferson, et al.
Publicado: (2021)

Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report()
por: Arai, Tatsuya, et al.
Publicado: (2022)

Bendamustine/ciclesonide/obinutuzumab: Diarrhoea following off-label use and prolonged viral shedding: case report
Publicado: (2021)

Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021)

Remdesivir/tocilizumab: Rebound of HCV viral load and loss of anti-HBs: case report
Publicado: (2021)

Bendamustine/dexamethasone/rituximab: Cytomegalovirus reactivation : case report
Publicado: (2021)

Bendamustine/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

Bendamustine/rituximab: Neutropenia, fever and inflammation: case report
Publicado: (2022)

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis
por: Smilek, Dawn Elaine, et al.
Publicado: (2017)

Good's syndrome: Thymoma with hypogammaglobulinaemia
por: Mathew, Anoop, et al.
Publicado: (2020)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia
por: Zhang, Ting, et al.
Publicado: (2021)

Dementia in a patient with Thymoma and hypogammaglobulinaemia (Good's syndrome)
por: de Jesus, Nelson Pedro Ferreira, et al.
Publicado: (2008)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
por: Bega, Giulia, et al.
Publicado: (2021)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
por: Saito, H, et al.
Publicado: (2015)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
por: Saito, H, et al.
Publicado: (2017)

Painful, plantar nodules in cutaneous macroglobulinosis: Successful treatment with rituximab and bendamustine
por: D'Acunto, Carmine, et al.
Publicado: (2020)

Large B - Cell Lymphoma of the Leg – Unfavourable Course with Rituximab/Bendamustin
por: Wollina, Uwe, et al.
Publicado: (2019)

Multiple drugs: Lymphocytopenia and off-label use: case report
Publicado: (2020)

Multiple drugs: Thrombocytopenic purpura, leucopenia and lymphocytopenia: case report
Publicado: (2021)

Cyclophosphamide/fludarabine/rituximab: Prolonged viral shedding and protracted COVID-19: case report
Publicado: (2022)

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report
por: Monteiro, Rowan, et al.
Publicado: (2017)

Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease
por: Mondello, Patrizia, et al.
Publicado: (2014)

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
por: Kamegai, Kohei, et al.
Publicado: (2022)

Remdesivir: Rebound effect in the form of SARS-CoV-2 infection following off label use: 2 case reports
Publicado: (2022)

Paraneoplastic acute fibrinous and organizing pneumonia from lymphoma completely responding to bendamustine‐rituximab
por: Crowhurst, Thomas, et al.
Publicado: (2020)

Bendamustine/obinutuzumab/remdesivir: Absence of CD19-B lymphocytes, decrease in CD4-T lymphocytes and lack of efficacy: case report
Publicado: (2021)

Dexamethasone/remdesivir/rituximab: Hypotension, dyspnoea and lack of efficacy following off-label use: case report
Publicado: (2021)

Two rare cases of bronchus‐associated lymphoid tissue lymphoma successfully treated with rituximab‐bendamustine
por: Panitz, Nydia, et al.
Publicado: (2021)

Idiopathic CD4+ T lymphocytopenia: A case report
por: Umamaheshwari, S, et al.
Publicado: (2020)

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
por: Visentin, Andrea, et al.
Publicado: (2017)

B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases
por: Wang, Anna, et al.
Publicado: (2023)

Multidrug-resistant HIV viral rebound during early syphilis: a case report
por: Giacomelli, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jun3ui8ajhuc99hj8a263ll16a